Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment. Munroe ES, Grandits GA, Hyzy RC, Prescott HC, et al. PLoS One 2025;20:e0325561.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Munroe ES, Grandits GA, Hyzy RC, Prescott HC, et al. Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment. PLoS One 2025;20:e0325561.
PMID: 40531973